13 June 2018
A new guide to the AHSN Network is published today (Wednesday 13 June), detailing the impact to date of England’s 15 Academic Health Science Networks (AHSNs), as well as outlining future plans for the years ahead.
The AHSNs were first licensed by NHS England in 2013 for an initial period of five years, and in that time they have pioneered new ways to spread and adopt healthcare innovation.
At its board meeting in May, NHS England formally approved a new five-year licence for the AHSNs, as part of its 10-year vision to drive health innovation and stimulate economic growth.
The report highlights the collective achievements of the AHSNs so far, which include:
On top of this, 1,242 NHS sites are now using solutions developed by Fellows of the NHS Innovation Accelerator, the NHS England initiative delivered in partnership with the AHSNs.
Over 150 companies have been supported by our innovation development programme, SBRI Healthcare – delivering over £19 million annual recurring savings to health and care.
And through the work of the 15 Patient Safety Collaboratives hosted by AHSNs in partnership with NHS Improvement, there has been a 67% reduction in acute kidney injury (AKI) mortality, while sepsis mortality has reduced by 24%.
The report also features case studies on seven of the AHSNs’ programmes, which have been identified for national adoption and spread across Network in 2018-20. These are:
In addition to the work with NHS England and NHS Improvement, the government’s Office for Life Sciences is also funding AHSNs to coordinate a network of Innovation Exchanges across England, building on AHSNs’ unique expertise and cross-sector connections to match health needs with potential solutions.
Professor Mike Hannay, Chair of the AHSN Network, said: “It’s been quite a journey since the 15 AHSNs were first established back in 2013. While there have been challenges and obstacles along the way, AHSNs have rapidly become a vital part of the country’s health economy, connecting and brokering partnerships between health and care, academia, the third sector and industry.
“With what seems like a current explosion of innovation and new technologies, the role of the AHSNs isn’t simply to support the NHS in identifying those in which to invest, but also in helping to build health and care ecosystems, with cultures, leadership and pathways ready to accept and work with these new solutions.
“In our new licence from NHS England, the 15 AHSNs will develop this role as the key innovation arm of the NHS; supporting our health and care partners to deliver improvements that lead to better patient outcomes, drive down the cost of care and stimulate economic growth.”
To find out more about the healthcare solutions developed and spread with support from the AHSNs, visit the AHSN Atlas, many of which have been showcased in our ongoing NHS 70 Innovations campaign in partnership with NHS Digital.